Many patients will develop long-term symptoms of the new crown after being infected with the new crown. The long-term symptoms of the new crown are also called the acute sequelae of the new coronary pneumonia, which is usually defined as the new coronary pneumonia that lasts for more than 30 days. symptom.
A study published in “medRxiv” shows that long-term symptoms of the new crown have many manifestations:
brain fog
fatigue
exercise shortness of breath
headache
palpitations
body pain
tachycardia and dizziness
the research team aimed to A survey of 2,314 adult patients found that 67% of long-term COVID-19 patients had moderate-to-severe autonomic dysregulation (disorder), said Lauren Stiles, research assistant professor of neurology. Neurological dysfunction.
It is estimated that 38 million Americans have long-term COVID-19 autonomic dysfunction.” As for post-pandemic symptom severity and self-discipline Whether the degree of neurological disorders is related or not, according to the research team, the two are unrelated, which means that even mild symptoms and mild infections can lead to serious autonomic nervous disorders (disorders).
In addition, the autonomic nervous system plays an important role in the control of blood coagulation and immune function, both of which appear to be associated with long-term COVID-19 symptoms, although the exact association requires further scrutiny.
Inoculation of the fourth dose of the new crown vaccine
Reduce hospital mortality
Reducing the chance of infection can reduce the occurrence of long-term new crown symptoms. At present, certain ethnic groups have been opened in China The fourth dose of the new crown vaccine, according to an Israeli study, showed that the fourth dose of the vaccine could reduce the mortality rate after hospitalization.
The study observed patients for up to half a year and found that compared with patients who received the third dose of the vaccine, those who received the fourth dose of the vaccine were 3.5 times less likely to develop severe disease. Overall, The fourth dose of the new coronary pneumonia vaccine reduces severe disease and mortality. In the face of the Omicron pandemic, the fourth dose of the vaccine is beneficial for high-risk groups.